NCT02255370 Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease Status COMPLETED Phase PHASE3
NCT02249078 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease Status WITHDRAWN Phase PHASE1
NCT02245594 GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease Status UNKNOWN Phase N/A
NCT02240121 One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease Status TERMINATED Phase PHASE3
NCT02240108 One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease Status TERMINATED Phase PHASE3
NCT02233062 Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's Disease Status COMPLETED Phase NA
NCT02231814 The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's Disease Status COMPLETED Phase NA
NCT02225795 Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease. Status WITHDRAWN Phase NA
NCT02213835 Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis Status COMPLETED Phase NA
NCT02208310 Trial of High Dose Vitamin D in Patient's With Crohn's Disease Status TERMINATED Phase PHASE4
NCT02201693 Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease Status COMPLETED Phase NA
NCT02199561 Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02197780 Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD Status COMPLETED Phase N/A
NCT02193802 Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease Status UNKNOWN Phase NA
NCT02193750 Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease Status TERMINATED Phase NA
NCT02193048 Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease Status COMPLETED Phase N/A
NCT02185183 Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase PHASE1/PHASE2
NCT02185014 Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115 Status COMPLETED Phase PHASE3
NCT02179372 Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases Status COMPLETED Phase NA